Cutting Edge: Tumor-Targeting Antibodies Enhance NKG2D-Mediated NK Cell Cytotoxicity by Stabilizing NK Cell-Tumor Cell Interactions

Journal of Immunology - United States
doi 10.4049/jimmunol.1202065
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Cutting Edge: Novel Priming of Tumor-Specific Immunity by NKG2D-Triggered NK Cell-Mediated Tumor Rejection and Th1-Independent CD4+ T Cell Pathway

Journal of Immunology
AllergyImmunology
2004English

STAT1 Ser727 – Key Regulator for NK Cell-Mediated Cytotoxicity and Tumor Surveillance

BMC Pharmacology
2008English

Increase of NKG2D Ligands and Sensitivity to NK Cell-Mediated Cytotoxicity of Tumor Cells by Heat Shock and Ionizing Radiation

Experimental & Molecular Medicine
2006English

Cutting Edge: Activation of NK Cell-Mediated Cytotoxicity by a SAP-Independent Receptor of the CD2 Family

Journal of Immunology
AllergyImmunology
2001English

Sensitization of Tumor Cells to NK Cell-Mediated Killing by Proteasome Inhibition

Journal of Immunology
AllergyImmunology
2007English

NKG2D Signaling Leads to NK Cell Mediated Lysis of Childhood AML

Journal of Immunology Research
MedicineAllergyImmunology
2015English

Loss of STAT3 in Lymphoma Relaxes NK Cell-Mediated Tumor Surveillance

Cancers
Cancer ResearchOncology
2014English

The Balancing Act: Inhibitory Ly49 Regulate NKG2D-mediated NK Cell Functions

Seminars in Immunology
AllergyImmunology
2006English

Cutting Edge: Thymic NK Cells Develop Independently From T Cell Precursors

Journal of Immunology
AllergyImmunology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy